Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Hi-Tech Pharmacal Co Inc HITK

Healthcare Drug Manufacturers - Specialty & Generic

Recent & Breaking News (NDAQ:HITK)

Rigrodsky & Long, P.A. Announces Investigation Of Hi-Tech Pharmacal Co., Inc. Buyout

Business Wire August 29, 2013

HI-TECH PHARMACAL CO. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Hi-Tech Pharmacal Co.

Business Wire August 29, 2013

HI-TECH PHARMACAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Hi-Tech Pharmacal Co., Inc. Following Announcement of Proposed Sale of Company to Akorn, Inc.

Business Wire August 28, 2013

Faruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Hi-Tech Pharmacal Co., Inc. Over the Proposed Sale of the Company to Akorn, Inc.

Business Wire August 28, 2013

Morgan & Morgan Announces the Investigation of Hi-Tech Pharmacal Co., Inc. HITK

PR Newswire August 28, 2013

HI-TECH PHARMACAL CO. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Hi-Tech Pharmacal Co.

Business Wire August 28, 2013

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Hi-Tech Pharmacal Co., Inc. Shareholders

Business Wire August 28, 2013

Attention HITK Shareholders: The Proposed Buyout of Hi-Tech Pharmacal Co., Inc. by Akorn, Inc. under Investigation by The Young Law Firm

Business Wire August 28, 2013

Ryan & Maniskas, LLP Announces Investigation of Hi-Tech Pharmacal Co., Inc.

PR Newswire August 28, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Hi-Tech Pharmacal Co., Inc. - HITK

PR Newswire August 27, 2013

Acquisition of Hi-Tech Pharmacal Co., Inc. by Akorn, Inc. May Not Be in the Best Interests of Hi-Tech Pharmacal Co., Inc. Shareholders

PR Newswire August 27, 2013

Hi-Tech Pharmacal Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate Acquisition by Akorn, Inc.

Business Wire August 27, 2013

Hi Tech Shareholder Alert - Buyout Of Hi Tech - Law Firm Seeks Higher Price For Shareholders

PR Newswire August 27, 2013

Rigrodsky & Long, P.A. Announces Investigation Of Hi-Tech Pharmacal Co., Inc. Buyout

Business Wire August 27, 2013

Harwood Feffer LLP Announces Investigation of Hi-Tech Pharmacal Co.

PR Newswire August 27, 2013

Hi-Tech Pharmacal Co., Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Akorn, Inc.

PR Newswire August 27, 2013

Akorn to Acquire Hi-Tech Pharmacal for $640 Million

Business Wire August 27, 2013

Health Care Products Division of Hi-Tech Pharmacal Receives FDA Warning Letter Related to Labeling Statements on Certain OTC Products

Business Wire July 24, 2013

Hi-Tech Pharmacal Reports Sales of $58.5 million for the Fourth Quarter Ended April 30, 2013

Business Wire July 9, 2013

Hi-Tech Pharmacal to Release Fourth Quarter Earnings and Hold Conference Call on July 9, 2013

Business Wire July 3, 2013